Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Intergroup Randomized Phase III Study of Postoperative Irinotecan, 5-Fluorouracil and Leucovorin vs. Oxaliplatin, 5-Fluorouracil and Leucovorin vs. 5-Fluorouracil and Leucovorin for Patients With Stage II or III Rectal Cancer Receiving Either Preoperative Radiation and 5-Fluorouracil or Postoperative Radiation and 5-Fluorouracil

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00068692
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:04.682297+00:00
Published At
2018-12-04T00:00:00+00:00
Record Updated At
2018-12-04
Results Posted At
2018-12-04
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Rectal Mucinous Adenocarcinoma", "Rectal Signet Ring Cell Adenocarcinoma", "Recurrent Rectal Carcinoma", "Stage IIA Rectal Cancer AJCC v7", "Stage IIB Rectal Cancer AJCC v7", "Stage IIC Rectal Cancer AJCC v7", "Stage IIIA Rectal Cancer AJCC v7", "Stage IIIB Rectal Cancer AJCC v7", "Stage IIIC Rectal Cancer AJCC v7", "Stage IVA Rectal Cancer AJCC v7", "Stage IVB Rectal Cancer AJCC v7"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-12-04"
protocolSection.identificationModule.nctId
"NCT00068692"
protocolSection.identificationModule.officialTitle
"Intergroup Randomized Phase III Study of Postoperative Irinotecan, 5-Fluorouracil and Leucovorin vs. Oxaliplatin, 5-Fluorouracil and Leucovorin vs. 5-Fluorouracil and Leucovorin for Patients With Stage II or III Rectal Cancer Receiving Either Preoperative Radiation and 5-Fluorouracil or Postoperative Radiation and 5-Fluorouracil"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2018-12-04"

Study condition terms

  • Rectal Mucinous Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Rectal Signet Ring Cell Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Rectal Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IIA Rectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIB Rectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIC Rectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Rectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Rectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIC Rectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVA Rectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVB Rectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.